Icon PLC (ICLR): Depreciation & Amortization
$383.00M
Year ended 2025-12-31
-12.4%
3-year compound annual growth
+42.1%
5-year compound annual growth
+20.8%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $383.00M | -21.6% | 2026-05-27, From 2025-01-01 |
| 2024-12-31 | $488.50M | -16.6% | 2026-05-27, From 2024-01-01 |
| 2023-12-31 | $585.95M | +2.9% | 2026-05-27, From 2023-01-01 |
| 2022-12-31 | $569.51M | +80.8% | 2025-02-21, From 2022-01-01 |
| 2021-12-31 | $314.99M | +376.3% | 2024-02-23, From 2021-01-01 |
| 2020-12-31 | $66.13M | +7.4% | 2023-02-24, From 2020-01-01 |
| 2019-12-31 | $61.55M | -6.6% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $65.92M | +7.5% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $61.30M | +2.9% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $59.58M | +3.3% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $57.68M | +9.8% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $52.54M | +13.0% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $46.51M | +8.6% | 2016-03-23, From 2013-01-01 |
| 2012-12-31 | $42.82M | +10.7% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $38.68M | +14.2% | 2014-03-12, From 2011-01-01 |
| 2010-12-31 | $33.87M | +3.7% | 2013-03-06, From 2010-01-01 |
| 2009-12-31 | $32.66M | +17.8% | 2012-03-02, From 2009-01-01 |
| 2008-12-31 | $27.73M | n/a | 2011-03-22, From 2008-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Icon PLC (ICLR) | 2025-12-31 | $383.00M | -21.6% |
| Incyte Corp (INCY) | 2025-12-31 | $93.29M | +4.5% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $1.14B | +2.7% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $403.31M | +11.5% |
| NRC Health (NRC) | 2025-12-31 | $7.62M | +26.6% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $4.34M | +0.6% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $21.75M | -7.8% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $597.4K | -51.6% |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | $504.8K | -16.6% |
Compare ICLR, INCY, IQV, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗